• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT CG4+ CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT CG4+ CARTRIDGE Back to Search Results
Catalog Number 03P85-25
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Information (3190)
Date of Event 09/19/2015
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Apoc labeling was evaluated during the investigation as pertaining to the event.The investigation was completed on 11/25/2015.Retain product was tested and functioning according to specification.Return product was not available for investigation.Investigation: the device history record (dhr) for this lot was reviewed.The lot passed finished goods (fg) release criteria.Forty retained cartridges from the lot were tested using a whole blood (wb) sample and i-stat tricontrols level 1 control (l1).The customer complaint was not reproduced.Testing met the acceptance criteria found in q04.01.003 rev.W, appendix 1 - product complaint level 2 and level 3 investigation procedure.No deficiency has been identified.Assessment: the complaint investigation concluded there was no product deficiency and that the i-stat cartridge lot is meeting specification.
 
Event or Problem Description
On (b)(6) 2015, abbott point of care was contacted by a customer regarding i-stat cg4+ cartridges that yielded suspected discrepant ph and pc02 results on a patient.There was no additional patient information available at the time of this report.Return product is not available for investigation.A patient sample was tested on (b)(6) 2015 with following results: ph = 6.88, pco2 = >17 kpa; the result was queried by the doctor and the sample was repeated in the lab: ph = 7.0, pco2 = 8; customer has run other samples since then with no unexpected results.At the time of the event there was no indication of a product malfunction based on the information provided and assessed by apoc, however this mdr is a retrospective filing in response to an observation from an fda inspection conducted may 8th to 12th, 2017 at abbott point of care ((b)(4)).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT CG4+ CARTRIDGE
Common Device Name
CG4+ CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
MDR Report Key6932280
Report Number2245578-2017-00337
Device Sequence Number699701
Product Code KHP
UDI-Device Identifier10054749000132
UDI-Public10054749000132
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K982071
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 10/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/28/2015
Device Catalogue Number03P85-25
Device Lot NumberM15065A
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/13/2017
Initial Report FDA Received Date10/09/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-